Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

Journal of Medical Virology

Volumn 79, Issue 6, 2007, Pages 758-765

  Blossom, D B ^a,e   Beigi, R H ^b   Farrell, J J ^a   Mackay, W ^a   Qadadri, B ^c   Brown, D R ^c   Rwambuya, S ^a   Walker, C J ^a   Kambugu, F S ^d   Abdul Karim, F W ^a   Whalen, C C ^a   Salata, R A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ugandan National Sexually Transmitted Diseases Referral Centre   (Uganda)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cervical cancer; Cervical cytologic abnormalities; HPV genotypes; Human immunodeficiency virus (HIV); Human papillomavirus (HPV)

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPANICOLAOU TEST; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; UGANDA; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 34248209760     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20817     Document Type: Article

References (26)

1. Baay MFD, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG. 2004. Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 73:481-485.
2. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. 1999. Detection of multiple human papillomavirus types in condyloma accuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37:3316-3322.
3. Brown DR, Legge D, Qadadri B. 2002. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 29:763-768.
4. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. 2005. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191:182-192.
5. Cronje HS. 2004. Screening for cervical cancer in developing countries. Int J Gynaecol Obstet 84:101-108.
6. De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M. 2003. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 30:137-142.
7. Frisch M, Biggar BJ, Goedert JJ. 2000. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-1510.
8. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial. Lancet 364:1757-1765.
9. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Toure P, Kasse AA, Dembele B, Sow PS, Coll-Seck AM, Kuypers JM, Kiviat NB. 2003. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 188:555-563.
10. Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. 2000. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 96:403-409.
11. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1375.
12. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651.
13. Lack N, West B, Jeffries D, Ekpo G, Morison L, Soutter WP, Walraven G, Boryseiwicz L. 2005. Comparison of non-invasive sampling methods for detection of HPV in rural african women. Sex Transm Infect 81:239-241.
14. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101:40-45.
15. Marais DJ, Vardas E, Ramjee G, Allan B, Kay P, Rose RC, Williamson AL. 2000. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. J Infect Dis 182:1239-1242.
16. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh H, Coutinho A, Engels EA. 2006. Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118:985-990.
17. Oglivie GS, Patrick DM, Schulzer M, Sellars JW, Petric M, Chambers K, White R, Fitzgerald JM. 2005. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: A meta-analysis. Sex Transm Infect 81: 207-212.
18. Rein MF. 2000. The interaction between HIV and the classic sexually transmitted diseases. Curr Infect Dis Rep 2:87-95.
19. Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, Schiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G. 1999. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 82:334-337.
20. Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, Li C, Lorinez A, Meehan MP, Wabwire-Mangen F, Gray RH. 1999. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 180: 1316-1319.
21. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Change-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X. 1992. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 51:515-521.
22. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa J. 1993. Cancer in Kampala, Uganda: Changes in incidence in the era of AIDS. Int J Cancer 54:26-36.
23. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. 1994. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 83:205-211.
24. World Health Organization. 2003. HIV Testing and Counselling: The Gateway to Treatment, Care and Support. Available at http:// www.who.int/3by5/ publications/briefs/hivtestingcounselling/en/ index.html. Accesseds October 28, 2005.
25. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. 2000. HPV testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283:81-86.
26. Wright TC, Cox T, Massad S. 2002. The 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. JAMA 287:2120-2129.